Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 3 years
- Director since
- 2024
3 years of board service in total across 1 board, counting each seat separately. Longest: Akari Therapeutics plc, 2 years.
Akari Therapeutics plc
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jul 7, 2026 | Akari Therapeutics plc | Option exercise | +1,209 | $8.00 | $9,672 |
| Jul 7, 2026 | Akari Therapeutics plc | Option exercise | +15,466 | $0.00 | $6 |
| Jul 7, 2026 | Akari Therapeutics plc | Option exercise | +5,799 | $0.00 | $2 |
| Mar 6, 2025 | Akari Therapeutics plc | Grant or award | +406,250 | $1.12 | $455,000 |
| Jan 3, 2025 | Akari Therapeutics plc | Grant or award | +208,000 | — | — |
| Dec 27, 2024 | Akari Therapeutics plc | Grant or award | +400,000 | — | — |
| Dec 26, 2024 | Akari Therapeutics plc | Grant or award | +3,200,000 | — | — |
| Dec 24, 2024 | Akari Therapeutics plc | Grant or award | +7,500,000 | — | — |
| Dec 23, 2024 | Akari Therapeutics plc | Grant or award | +1,400,000 | — | — |
| Dec 20, 2024 | Akari Therapeutics plc | Grant or award | +1,400,000 | — | — |
| Dec 2, 2024 | Akari Therapeutics plc | Grant or award | +419,286,000 | — | — |
| Nov 14, 2024 | Akari Therapeutics plc | Grant or award | +1,404,622,000 | — | — |
| Jun 30, 2024 | Akari Therapeutics plc | Grant or award | +91,396,000 | — | — |
| May 31, 2024 | Akari Therapeutics plc | Grant or award | +1,326,258,000 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.